Annual Drug Patent Expirations for XOFLUZA
Xofluza is a drug marketed by Genentech Inc and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug.
This drug has one hundred and seventy-four patent family members in thirty-nine countries.
The generic ingredient in XOFLUZA is baloxavir marboxil. One supplier is listed for this compound. Additional details are available on the baloxavir marboxil profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
